Pacific Biosciences of California, Inc. Stock
Equities
PACB
US69404D1081
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.47 USD | +6.52% | -5.16% | -85.02% |
Sales 2024 * | 193M 264M | Sales 2025 * | 285M 389M | Capitalization | 400M 547M |
---|---|---|---|---|---|
Net income 2024 * | -283M -387M | Net income 2025 * | -235M -321M | EV / Sales 2024 * | 4.31 x |
Net Debt 2024 * | 432M 590M | Net Debt 2025 * | 502M 686M | EV / Sales 2025 * | 3.17 x |
P/E ratio 2024 * |
-1.41
x | P/E ratio 2025 * |
-1.74
x | Employees | 796 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.18% |
Latest transcript on Pacific Biosciences of California, Inc.
1 day | +6.52% | ||
1 week | -5.16% | ||
Current month | -60.80% | ||
1 month | -58.24% | ||
3 months | -79.06% | ||
6 months | -79.44% | ||
Current year | -85.02% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Turner
FOU | Founder | 56 | 00-07-13 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Susan Kim
DFI | Director of Finance/CFO | 48 | 20-09-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Milligan
CHM | Chairman | 63 | 13-07-17 |
Marshall Mohr
BRD | Director/Board Member | 67 | 12-01-17 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.87% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.47 | +6.52% | 7,986,911 |
24-04-25 | 1.38 | +1.47% | 9,989,457 |
24-04-24 | 1.36 | -7.48% | 11,064,874 |
24-04-23 | 1.47 | -5.77% | 9,818,090 |
24-04-22 | 1.56 | +0.65% | 8,964,453 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.02% | 400M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B | |
+26.76% | 32.03B |
- Stock Market
- Equities
- PACB Stock